[Use of aprotinin in cardiovascular surgery].
作者信息
Colorio C, Carreras L O
机构信息
Instituto de Cardiología y Cirugía Cardiovascular, Fundación Favaloro, Buenos Aires, Argentina.
出版信息
Sangre (Barc). 1995 Jun;40(3):207-11.
PMID:7570273
Abstract
摘要
相似文献
1
[Use of aprotinin in cardiovascular surgery].[抑肽酶在心血管外科手术中的应用]
Sangre (Barc). 1995 Jun;40(3):207-11.
2
[Aprotinin in the control of surgical hemorrhage].[抑肽酶在控制手术出血中的应用]
Med Clin (Barc). 1996 Mar 2;106(8):307-16.
3
Suction, salvage, sutures, and potions: blood management post-aprotinin.抽吸、挽救、缝合与药剂：抑肽酶停用后的血液管理
Semin Cardiothorac Vasc Anesth. 2009 Jun;13(2):122-6. doi: 10.1177/1089253209337159. Epub 2009 Jul 17.
4
Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
Semin Thromb Hemost. 1993;19(3):302-5. doi: 10.1055/s-2007-994047.
5
Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery.无抑肽酶生存：心脏手术中一项为期5年的血液节约计划的结果
Acta Anaesthesiol Scand. 2009 May;53(5):573-80. doi: 10.1111/j.1399-6576.2008.01899.x. Epub 2009 Jan 23.
6
Can we really believe that aprotinin is safe in congenital heart surgery?我们真的能相信抑肽酶在先天性心脏手术中是安全的吗？
Ann Thorac Surg. 2011 Mar;91(3):987-8; author reply 988. doi: 10.1016/j.athoracsur.2010.07.106.
7
Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.氨甲环酸与抑肽酶在心脏初次手术中的应用：对220例接受氨甲环酸或抑肽酶治疗的心脏手术患者的分析
Anesth Analg. 2008 Nov;107(5):1469-78. doi: 10.1213/ane.0b013e318182252b.
8
Lessons learned in antifibrinolytic therapy: The BART trial.抗纤溶治疗的经验教训：BART试验。
Semin Cardiothorac Vasc Anesth. 2009 Jun;13(2):127-31. doi: 10.1177/1089253209338076.
9
Aprotinin in orthotopic liver transplantation.
Semin Thromb Hemost. 1993;19(3):262-7. doi: 10.1055/s-2007-994037.
10
Editorial comment.编者按
Eur J Cardiothorac Surg. 2009 Nov;36(5):875-6. doi: 10.1016/j.ejcts.2009.05.015.
Zotero 插件